SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-16-016343
Filing Date
2016-05-13
Accepted
2016-05-13 16:59:18
Documents
56
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q imuc-33116x10q.htm 10-Q 439758
2 EXHIBIT 10.1 imuc-33116xexhibit101.htm EX-10.1 60761
3 EXHIBIT 31.1 imuc-33116xexhibit311.htm EX-31.1 13217
4 EXHIBIT 31.2 imuc-33116xexhibit312.htm EX-31.2 13285
5 EXHIBIT 32.1 imuc-33116xexhibit321.htm EX-32.1 6358
6 EXHIBIT 32.2 imuc-33116xexhibit322.htm EX-32.2 6357
  Complete submission text file 0001628280-16-016343.txt   3491612

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT imuc-20160331.xml EX-101.INS 491797
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imuc-20160331.xsd EX-101.SCH 36538
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT imuc-20160331_cal.xml EX-101.CAL 48623
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT imuc-20160331_def.xml EX-101.DEF 145023
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imuc-20160331_lab.xml EX-101.LAB 494063
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imuc-20160331_pre.xml EX-101.PRE 269980
Mailing Address 23622 CALABASAS ROAD SUITE 300 CALABASAS CA 91302
Business Address 23622 CALABASAS ROAD SUITE 300 CALABASAS CA 91302 818-264-2300
ImmunoCellular Therapeutics, Ltd. (Filer) CIK: 0000822411 (see all company filings)

IRS No.: 931301885 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35560 | Film No.: 161649216
SIC: 2834 Pharmaceutical Preparations